China Bans Sibutramine: Weight Loss Drug Poses Serious Cardiovascular Risks

Recently, the State Food and Drug Administration announced that based on comprehensive monitoring and evaluation results both domestically and internationally, the use

Sibutramine Use Banned in China: Severe Cardiovascular Risks Outweigh Benefits

Recently, the National Medical Products Administration announced that based on the comprehensive monitoring and evaluation results, the use of sibutramine may increase the risk of severe cardiovascula